JPS5939430B2 - Bistetrazolium salt compound and spectrophotometric determination of dehydrogenase using the compound - Google Patents
Bistetrazolium salt compound and spectrophotometric determination of dehydrogenase using the compoundInfo
- Publication number
- JPS5939430B2 JPS5939430B2 JP21461981A JP21461981A JPS5939430B2 JP S5939430 B2 JPS5939430 B2 JP S5939430B2 JP 21461981 A JP21461981 A JP 21461981A JP 21461981 A JP21461981 A JP 21461981A JP S5939430 B2 JPS5939430 B2 JP S5939430B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- carbon atoms
- added
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 salt compound Chemical class 0.000 title claims description 29
- 150000001875 compounds Chemical class 0.000 title claims description 28
- 101710088194 Dehydrogenase Proteins 0.000 title claims description 11
- 238000002798 spectrophotometry method Methods 0.000 title claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 229910052801 chlorine Inorganic materials 0.000 claims description 9
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 9
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 238000006467 substitution reaction Methods 0.000 claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 87
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 30
- 239000000243 solution Substances 0.000 description 25
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 24
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 23
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 22
- 238000006243 chemical reaction Methods 0.000 description 17
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 15
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 8
- 150000007857 hydrazones Chemical class 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- JQJPBYFTQAANLE-UHFFFAOYSA-N Butyl nitrite Chemical compound CCCCON=O JQJPBYFTQAANLE-UHFFFAOYSA-N 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 7
- 238000000921 elemental analysis Methods 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 125000005415 substituted alkoxy group Chemical group 0.000 description 7
- PKDBCJSWQUOKDO-UHFFFAOYSA-M 2,3,5-triphenyltetrazolium chloride Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC=CC=2)=NN1C1=CC=CC=C1 PKDBCJSWQUOKDO-UHFFFAOYSA-M 0.000 description 6
- NARVIWMVBMUEOG-UHFFFAOYSA-N 2-Hydroxy-propylene Natural products CC(O)=C NARVIWMVBMUEOG-UHFFFAOYSA-N 0.000 description 6
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 description 4
- IAVREABSGIHHMO-UHFFFAOYSA-N 3-hydroxybenzaldehyde Chemical compound OC1=CC=CC(C=O)=C1 IAVREABSGIHHMO-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 108020005199 Dehydrogenases Proteins 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- KMVPXBDOWDXXEN-UHFFFAOYSA-N 4-nitrophenylhydrazine Chemical compound NNC1=CC=C([N+]([O-])=O)C=C1 KMVPXBDOWDXXEN-UHFFFAOYSA-N 0.000 description 3
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 3
- 229940067157 phenylhydrazine Drugs 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 125000003831 tetrazolyl group Chemical group 0.000 description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- XEFCBKRSYOWBFD-UHFFFAOYSA-N 4-(4-chlorobutoxy)benzaldehyde Chemical compound ClCCCCOC1=CC=C(C=O)C=C1 XEFCBKRSYOWBFD-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 108091006149 Electron carriers Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 2
- 239000000370 acceptor Substances 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000005265 dialkylamine group Chemical group 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- JGOAZQAXRONCCI-SDNWHVSQSA-N n-[(e)-benzylideneamino]aniline Chemical compound C=1C=CC=CC=1N\N=C\C1=CC=CC=C1 JGOAZQAXRONCCI-SDNWHVSQSA-N 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 125000000466 oxiranyl group Chemical group 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- UOORRWUZONOOLO-OWOJBTEDSA-N (E)-1,3-dichloropropene Chemical group ClC\C=C\Cl UOORRWUZONOOLO-OWOJBTEDSA-N 0.000 description 1
- KJDRSWPQXHESDQ-UHFFFAOYSA-N 1,4-dichlorobutane Chemical compound ClCCCCCl KJDRSWPQXHESDQ-UHFFFAOYSA-N 0.000 description 1
- QITPSLQLANKSGE-UHFFFAOYSA-N 2-aminoacetic acid;2-hydroxypropanoic acid Chemical compound NCC(O)=O.CC(O)C(O)=O QITPSLQLANKSGE-UHFFFAOYSA-N 0.000 description 1
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 1
- QGZCUOLOTMJILH-UHFFFAOYSA-N 2h-tetrazol-2-ium;bromide Chemical compound [Br-].C1=N[NH+]=NN1 QGZCUOLOTMJILH-UHFFFAOYSA-N 0.000 description 1
- IXNHDPVJSRAWGR-UHFFFAOYSA-N 3-(3-chloropropoxy)benzaldehyde Chemical compound ClCCCOC1=CC=CC(C=O)=C1 IXNHDPVJSRAWGR-UHFFFAOYSA-N 0.000 description 1
- ZSPTYLOMNJNZNG-UHFFFAOYSA-N 3-Buten-1-ol Chemical group OCCC=C ZSPTYLOMNJNZNG-UHFFFAOYSA-N 0.000 description 1
- SSZWWUDQMAHNAQ-UHFFFAOYSA-N 3-chloropropane-1,2-diol Chemical compound OCC(O)CCl SSZWWUDQMAHNAQ-UHFFFAOYSA-N 0.000 description 1
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100459440 Caenorhabditis elegans nac-3 gene Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical group OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- GNHTYPGZSATHLQ-UHFFFAOYSA-N n-[(2-methoxyphenyl)methylideneamino]-4-nitroaniline Chemical compound COC1=CC=CC=C1C=NNC1=CC=C([N+]([O-])=O)C=C1 GNHTYPGZSATHLQ-UHFFFAOYSA-N 0.000 description 1
- NOIFWEYOLLHIMW-UVTDQMKNSA-N n-[(z)-benzylideneamino]-4-nitroaniline Chemical compound C1=CC([N+](=O)[O-])=CC=C1N\N=C/C1=CC=CC=C1 NOIFWEYOLLHIMW-UVTDQMKNSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000004031 phenylhydrazines Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
【発明の詳細な説明】
本発明は新規なビステトラゾリウム塩化合物およびその
化合物を用いる脱水素酵素の吸光光度定量法に関し、更
に詳しくは一般式で表わされるテトラゾリウム塩化合物
およびその化合物を用いる脱水素酵素の吸光光度定量法
に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel bistetrazolium salt compound and a method for spectrophotometric determination of dehydrogenase using the compound. Concerning the spectrophotometric determination method of
ただし式中の記号の意味はつぎのようである。Y:炭素
数が2〜4の直鎖式、または側1鎖を有しても良く、さ
らに必要に応じ1個の水酸基を有しても良いアルキレン
基。However, the meanings of the symbols in the formula are as follows. Y: A linear alkylene group having 2 to 4 carbon atoms, or an alkylene group that may have one side chain and, if necessary, may have one hydroxyl group.
R1二炭素数1〜4のアルキル基、またはヒドロキシエ
チル基。R1 is an alkyl group having 1 to 4 carbon atoms or a hydroxyethyl group.
R2:炭素数1〜4で、必要に応じ1〜2個の水酸基、
または1個のフエニル基を有しても良いアルキル基。R2: 1 to 4 carbon atoms, optionally 1 to 2 hydroxyl groups,
Or an alkyl group which may have one phenyl group.
R3:水素原子、またはニトロ基。R3: hydrogen atom or nitro group.
R4:メトキシ基:なおR3が水素原子のときはR4は
水素原子であつても良い。R4: Methoxy group: When R3 is a hydrogen atom, R4 may be a hydrogen atom.
X:塩素原子、または臭素原子。X: chlorine atom or bromine atom.
なお、−0Y−N−R1のベンゼン環における置換位置
は3位、または3位である。In addition, the substitution position in the benzene ring of -0Y-N-R1 is the 3-position or the 3-position.
本発明に係わる上述一般式(1)を有する化合物は文献
未載の新規物質であり、水素を受容してホルマザンを生
ずるため脱水素酵素の定量の目的に用いることができる
という大きな特色がある。The compound having the above general formula (1) according to the present invention is a new substance that has not been described in any literature, and has the great feature that it can be used for the purpose of quantifying dehydrogenases because it accepts hydrogen and produces formazan.
すなわち従来はテトラゾリウム塩化合物が脱水素酵素定
量のために用いられていたが、これが還元されて生じる
ホルマザンは、非水溶性のため実用上かなり不便であつ
た。ところで、今日ではホルマザン生成を利用した脱水
素酵素定量は広く普及し、特に臨床検査の分野では極め
て繁用される様になり、そのため現実には自動分析器を
用いて定量操作を行う機会が増してきている。ところが
その際に公知のテトラゾリウム塩を用いた場合は、操作
中に生じるホルマザンが水に不溶のため、これが分析器
のチユーブ内壁等に付着したり沈着したりするため検査
の自動化に大きな支障となつている。この様な欠点を解
消するためには、水に可溶件のホルマザンを作ることが
先決である。本発明はこの問題の解決に成功したもので
ある。以下に、本発明化合物の様に水素を受容して生じ
るホルマザンが水溶性である事が臨床検査上いかに有用
であるかを今少し詳しく説明する。脱水素酵素、たとえ
ば乳酸脱水素酵素(以下「LDH]と略記する。That is, conventionally, a tetrazolium salt compound has been used for quantifying dehydrogenase, but the formazan produced by reduction thereof is not water-soluble and is therefore quite inconvenient in practice. By the way, dehydrogenase quantification using formazan production is now widely used, especially in the field of clinical testing, and as a result, there are more and more opportunities to perform quantitative operations using automatic analyzers. It's coming. However, when known tetrazolium salts are used at that time, the formazan generated during the operation is insoluble in water, and this adheres to or deposits on the inner wall of the analyzer tube, which poses a major hindrance to the automation of testing. ing. In order to overcome these drawbacks, the first step is to create water-soluble formazan. The present invention successfully solves this problem. Below, we will explain in a little more detail how water-soluble formazan, which is produced by accepting hydrogen like the compound of the present invention, is useful in clinical tests. Dehydrogenases, such as lactate dehydrogenase (hereinafter abbreviated as "LDH").
)、アルコール脱水素酵素、グルタミン酸脱水素酵素等
は、これまでテトラゾリウム塩化合物を用いて定量分析
が行われてきた。すなわちテトラゾリウム塩化合物は、
これら各種脱水素酵素の作用により遊離した水素を中間
電子運搬体を介して受容することによりホルマザンを生
成する。そして、ここに生成したホルマザンの吸光度を
測定することにより脱水素酵素が定量できるのである。
ところで、これらの脱水素酵素のうちLDHはすべての
体細胞に分布し特に心筋、肝臓、骨格筋、腎臓等に多く
存在し、かつ心筋梗塞、悪性腫瘍、肝疾患、進行性筋委
縮、血管内溶血、巨赤芽球件貧血などの疾患の場合には
血清LDH活性が著しく土昇することが知られている。
従つて血中のLDH活姓を測定することにより臨床上、
上記の疾患の診断に対する極めて有意義な知見を得るこ
とができる。従来は土述の様にテトラゾリウム塩化合物
、たとネば3・3′一(3・37−ジメトキシ4・4′
\ビフエニリレン)−ビス〔2−(4−ニトロフエニル
)−5−フエニル一2Hテトラゾリウム塩化合物〕(以
下「ニトロTB」と略記する。), alcohol dehydrogenase, glutamate dehydrogenase, etc., have been quantitatively analyzed using tetrazolium salt compounds. That is, the tetrazolium salt compound is
Formazan is produced by accepting hydrogen liberated by the action of these various dehydrogenases via an intermediate electron carrier. Dehydrogenase can be quantified by measuring the absorbance of the formazan produced here.
By the way, among these dehydrogenases, LDH is distributed in all body cells, and is particularly present in large quantities in the heart muscle, liver, skeletal muscle, kidney, etc., and is associated with myocardial infarction, malignant tumors, liver disease, progressive muscle atrophy, and intravascular It is known that serum LDH activity increases markedly in cases of diseases such as hemolysis and megaloblastic anemia.
Therefore, clinically, by measuring LDH activity in the blood,
Extremely meaningful knowledge for diagnosis of the above-mentioned diseases can be obtained. Conventionally, as mentioned above, a tetrazolium salt compound, 3,3'-(3,37-dimethoxy4,4')
\biphenylylene)-bis[2-(4-nitrophenyl)-5-phenyl-2H tetrazolium salt compound] (hereinafter abbreviated as "nitro TB").
)などがこの目的のための水素受容体として一般に用い
られている。しかしながらこのニトロTBが水素を受容
して生じるホルマザンは水に全く溶けず、これは実用上
いろんな問題があつた。特に自動分析法の普及に伴い、
オートアナライザーが繁用されているが、その場合生成
ホルマザンが分析器のチユーブ等へ沈着し、爾後の操作
に支障を及ぼすことは致命的な欠点であつた。そのため
現在では界面活性剤等の分散剤を用いて該不溶件ホルマ
ザンを分散させた上で吸光光度定量しているが、これは
単に操作を繁雑化するのみにとどまらず、測定値に誤差
を生じさせる原因ともなり極めて好ましからぬことであ
つた。これらの欠点を除去するためには、生成ホルマザ
ンが水に溶け易い化合物を使用する必要がある。) are commonly used as hydrogen acceptors for this purpose. However, the formazan produced when this nitro-TB accepts hydrogen is completely insoluble in water, which poses various practical problems. Especially with the spread of automated analysis methods,
Although autoanalyzers are often used, the fatal drawback is that the formazan produced deposits in the tube of the analyzer, interfering with subsequent operations. Therefore, currently, the insoluble formazan is dispersed using a dispersant such as a surfactant and then the absorbance is determined, but this not only complicates the operation but also causes errors in the measured values. This was extremely undesirable as it also caused the problem to occur. In order to eliminate these drawbacks, it is necessary to use a compound in which the produced formazan is easily soluble in water.
その目的のためには、たとえば3−(4−ヨードフエニ
ル)−2−(4−ニトロフエニル)−5フエニル一2H
テトラゾリウム塩化物のような、生成ホルマザンの水溶
姓を若干土昇させた化合物も用いられているが、吸光光
度測定の目的のためには、該ホルマザンにおいてもなお
水溶性が小さすぎ実用上満足すべきものではない。本発
明者らは、溶解性が良く安定した測定値を与えるホルマ
ザンを生じさせる化合物について種種の研究を重ねた結
果、前記一般式(1)を有する化合物が水溶注の優れた
水素受容体であることを見いだして本発明を完成した。For that purpose, e.g. 3-(4-iodophenyl)-2-(4-nitrophenyl)-5phenyl-2H
Compounds such as tetrazolium chloride that slightly increase the water solubility of the produced formazan have also been used, but for the purpose of spectrophotometry, the water solubility of such formazan is still too low to be satisfactory for practical purposes. It's not a kimono. The present inventors have conducted various studies on compounds that produce formazan with good solubility and stable measurement values, and have found that the compound having the above general formula (1) is an excellent hydrogen acceptor for aqueous injection. They discovered this and completed the present invention.
従来においても、化合物の水溶性化法についてはいろい
ろと検討されており、中でもスルホン酸基の導入による
水溶性の向上はある程度試みられている。In the past, various methods for making compounds water-soluble have been studied, and among them, attempts have been made to some extent to improve water solubility by introducing sulfonic acid groups.
しかしこのようなスルホン酸誘導体は精製が困難である
事や、テトラゾリウム塩の状態ではむしろ水溶姓が低下
するなどの問題があつた。これに対し、4級アンモニウ
ム塩を側鎖に持つ本発明化合物は、これから生じるホル
マザンが水溶性に富むという極めて有利な特徴を有する
ため、この化合物を用いることによつて自動分析装置へ
の付着や沈殿の心配がなく、安定した測定値が得られる
定量方法が確立されたのである。本発明に係わる前記一
般式(1)を有する化合物は常法により製造することが
できる。However, such sulfonic acid derivatives have problems such as being difficult to purify and, in the form of tetrazolium salts, having rather poor water solubility. On the other hand, the compound of the present invention having a quaternary ammonium salt in its side chain has the extremely advantageous feature that the formazan produced from the compound is highly water-soluble. A quantitative method has been established that allows stable measurement values to be obtained without worrying about precipitation. The compound having the general formula (1) according to the present invention can be produced by a conventional method.
例をあげると、3(または4)−ヒドロキシベンズアル
デヒドに塩基性下でエピクロルヒドリン、または炭素数
が2ないし4のジハロゲン化アルキルを反応させ、対応
する3(または4)−アルコキシベンズアルデヒド類を
まず合成する。なお、オキシラン環を有するアルコキシ
ベンズアルデヒド化合物の場合は、氷冷下で塩酸、臭素
酸と反応させハロヒドリン化合物としても良い。さて、
ここで得られたアルコキシベンズアルデヒド類は、次い
でこれにフエニルヒドラジン類を作用させ、対応するヒ
ドラゾン化合物とする。このうちオキシラン環を有する
ヒドラゾン化合物は、ジアルキルアミンと反応させ側鎖
に3級アミンを有するヒドラゾン化合物とする。また側
鎖に・・ロゲンを有するヒドラゾン化合物はジアルキル
アミンと反応させても良い。次いで、これらヒドラゾン
化合物を塩基姓下で0−ジアニシジン、またはジベンジ
ジンαηゾニウム塩とカツプリング反応を行い、ジホル
マザン化合物とした後、側鎖に3級アミンを有するジホ
ルマザンはハロゲン化アルキルと、また側鎖にハロゲン
を持つホルマザンは3級アミンと反応させ、対応する4
級アンモニウム塩化合物を合成する。For example, the corresponding 3 (or 4)-alkoxybenzaldehyde is first synthesized by reacting 3 (or 4)-hydroxybenzaldehyde with epichlorohydrin or a dihalogenated alkyl having 2 to 4 carbon atoms under basic conditions. . In addition, in the case of an alkoxybenzaldehyde compound having an oxirane ring, it may be reacted with hydrochloric acid or bromic acid under ice cooling to form a halohydrin compound. Now,
The alkoxybenzaldehydes obtained here are then treated with phenylhydrazines to form the corresponding hydrazone compounds. Among these, the hydrazone compound having an oxirane ring is reacted with a dialkylamine to form a hydrazone compound having a tertiary amine in the side chain. Further, a hydrazone compound having . . . rogene in its side chain may be reacted with a dialkylamine. Next, these hydrazone compounds are subjected to a coupling reaction with 0-dianisidine or dibenzidine αη zonium salt in the presence of a base to form a diformazane compound, and then diformazane having a tertiary amine in the side chain is coupled with an alkyl halide and an alkyl halide in the side chain. Formazan containing a halogen is reacted with a tertiary amine, and the corresponding 4
Synthesize ammonium salt compounds.
次いで、このような4級アンモニウム塩を側鎖に有する
ジホルマザンを亜硝酸n−ブチル、N−ブロムコハク酸
イミド(以下「NBS]と略記する。等の酸化剤を用(
Zて酸化し、目的とするビステトラゾリウム塩化合物を
得る。これらの詳細は実施例においてさらに具体的にの
べる。次に、このようにして得られた一般式(1)を有
する化合物を用いる脱水素の吸光光度定量法につき説明
する。Next, diformazan having such a quaternary ammonium salt in its side chain was oxidized using an oxidizing agent such as n-butyl nitrite or N-bromosuccinimide (hereinafter abbreviated as "NBS").
Oxidation is performed using Z to obtain the desired bistetrazolium salt compound. These details will be described more specifically in the examples. Next, a method for spectrophotometric determination of dehydrogenation using the thus obtained compound having the general formula (1) will be explained.
すなわち脱水素酵素をリン酸緩衝液やトリス一塩酸緩衝
液などの中で該酵素に対応する基質と接触させる。ここ
で生成する水素は一旦ニコチンアミドアデニンジヌクレ
オチド(以下[NAD」と略記する。)に受容され、次
いでジアフオラーゼやフエナジンメトサルフエート(以
下「PMS」と略記する。)などの中間電子運搬体を介
して、本発明のビステトラゾリウム塩化合物に水素が受
容され、ここにおいて従来のホルマザンには認められな
い高度の水溶性を持つたホルマザンを生成する。そのた
め、生じた反応溶液の吸光度を直接測定することのみに
よつて、正確に目的酵素の活性値を定量する事ができる
。以下に実施例をあげて本発明を更に具体的に説明する
が、本発明はその要旨を超えない限り以下の実施例に制
約されるものではない。That is, a dehydrogenase is brought into contact with a substrate corresponding to the enzyme in a phosphate buffer, Tris monohydrochloride buffer, or the like. The hydrogen generated here is once accepted by nicotinamide adenine dinucleotide (hereinafter abbreviated as [NAD]), and then intermediate electron carriers such as diafluorase and phenazine methosulfate (hereinafter abbreviated as "PMS") Hydrogen is accepted by the bistetrazolium salt compound of the present invention via the body, thereby producing a formazan with a high degree of water solubility not found in conventional formazan. Therefore, the activity value of the target enzyme can be accurately quantified only by directly measuring the absorbance of the resulting reaction solution. The present invention will be described in more detail with reference to Examples below, but the present invention is not limited to the following Examples unless it exceeds the gist thereof.
実施例 1
(一般式(1)においてYが2−ヒドロキシプロピレン
、R1がエチル基、R2が2〜ヒドロキシエチル基、R
3がニトロ基、R4がメトキシ基、Xが塩素原子で、置
換アルコキシ基がベンゼン環の4位に置環した化合物の
合成法。Example 1 (In general formula (1), Y is 2-hydroxypropylene, R1 is ethyl group, R2 is 2-hydroxyethyl group, R
A method for synthesizing a compound in which 3 is a nitro group, R4 is a methoxy group, X is a chlorine atom, and a substituted alkoxy group is placed at the 4-position of a benzene ring.
)4−ヒドロキシベンズアルデヒド1147とエピクロ
ルヒドリン1707をテトラヒドロフランに溶かし、こ
こへ水酸化ナトリウム溶液を加え加熱還流させ減圧蒸留
して4−オキシランメトキシベンズアルデヒド1007
を得る。次に、この4オキシランメトキシベンズアルデ
ヒド507と4−ニトロフエニルヒドラジン43yをメ
タノール中で加温混合し、4−オキシランメトキシベン
ズアルデヒド−4−ニトロフエニルヒドラゾン857を
合成する。このヒドラゾン40yをメタノールに分散さ
せジエチルアミン307を加え加温後減圧濃縮し、4−
(2−ヒドロキシ−3−ジエチルアミノプロポキシ)ベ
ンズアルデヒド−4ニトロフエニルヒドラゾン49yを
得る。得られたヒドラゾン427をO−ジアニシジンテ
トラゾニウムホウフツ化塩24yと共にテトラヒドロフ
ランに懸濁させ冷却する。これに水酸化カリウム溶液を
徐々に滴下し2時間攪拌する。反応溶液にメタノールを
加え沢過し、41yの1・「(3・3′−ジメトキシ−
4・4′−ビフエニリレン)ビス{5−(4−ニトロフ
エニル)−3−〔4(2−ヒドロキシ−3−ジエチルア
ミノプロポキシ)フエニル〕}ジホルマザンを得る。得
られたジホルマザン407をエチレンクロルヒドリンに
懸濁させ加熱還流しながら反応させた後濃縮し、残渣に
テトラヒドロフランを加えジホルマザン側鎖の4級アン
モニウム塩407を得る。この4級アンモニウム塩25
7をメタノールに溶解しそれに塩酸を加え室温で攪拌し
ながら、ここへ亜硝酸ブチル15yを加えて反応させる
。反応溶液を沢過し減圧濃縮して、目的とするテトラゾ
リウム塩化物267を得る。融点 167〜17「C(
分解)
原素分析値(%)C58H7ONl2Cl4、H2O実
施例 2(実施例1で得られた化合物を用いる脱水素酵
素の吸光光度定量法。) 4-Hydroxybenzaldehyde 1147 and epichlorohydrin 1707 are dissolved in tetrahydrofuran, a sodium hydroxide solution is added thereto, heated to reflux, and distilled under reduced pressure to obtain 4-oxiranemethoxybenzaldehyde 1007.
get. Next, this 4-oxirane methoxybenzaldehyde 507 and 4-nitrophenylhydrazine 43y are heated and mixed in methanol to synthesize 4-oxirane methoxybenzaldehyde-4-nitrophenylhydrazone 857. This hydrazone 40y was dispersed in methanol, diethylamine 307 was added, heated and concentrated under reduced pressure.
(2-Hydroxy-3-diethylaminopropoxy)benzaldehyde-4nitrophenylhydrazone 49y is obtained. The obtained hydrazone 427 is suspended in tetrahydrofuran together with O-dianisidine tetrazonium borofluoride salt 24y and cooled. Potassium hydroxide solution was gradually added dropwise to the mixture and stirred for 2 hours. Methanol was added to the reaction solution, filtered, and the 41y 1.'(3.3'-dimethoxy-
4,4'-biphenylylene)bis{5-(4-nitrophenyl)-3-[4(2-hydroxy-3-diethylaminopropoxy)phenyl]}diformazane is obtained. The obtained diformazan 407 is suspended in ethylene chlorohydrin, reacted while heating under reflux, and then concentrated. Tetrahydrofuran is added to the residue to obtain the quaternary ammonium salt 407 of the diformazan side chain. This quaternary ammonium salt 25
7 was dissolved in methanol, hydrochloric acid was added thereto, and while stirring at room temperature, butyl nitrite 15y was added thereto for reaction. The reaction solution is filtered and concentrated under reduced pressure to obtain the desired tetrazolium chloride 267. Melting point 167~17"C (
Decomposition) Elemental analysis value (%) C58H7ONl2Cl4, H2O Example 2 (Spectrophotometric determination of dehydrogenase using the compound obtained in Example 1.
)37℃に予備加温したグリシン一乳酸塩溶液(グリシ
ン=0.72%、dl−乳酸=0.42%、PH−9.
6)4m1に同温度で30分間予備加温した標準血清を
O〜82.6mU/Ml,加え攪拌する。) Glycine monolactate solution prewarmed to 37°C (glycine = 0.72%, dl-lactic acid = 0.42%, PH-9.
6) Add 0 to 82.6 mU/Ml of standard serum pre-warmed at the same temperature for 30 minutes to 4 ml and stir.
1分後に実施例1で得られた化合物の0.0710%水
溶液を1m1加えて攪拌し、さらに1分後NAD−PM
S溶液(NAD−2%、PMSO.2%、牛血清アルブ
ミン留分5−0.15%、PH−7.4のリン酸緩衝液
)0.1m1を加えて攪拌し、37℃に正確に8分間保
つ。After 1 minute, 1 ml of 0.0710% aqueous solution of the compound obtained in Example 1 was added and stirred, and after another minute, NAD-PM
Add 0.1 ml of S solution (NAD-2%, PMSO.2%, bovine serum albumin fraction 5-0.15%, phosphate buffer of pH-7.4), stir, and heat to 37°C. Hold for 8 minutes.
ただちに0.1規定塩酸1m1を加え、590nmで吸
光度を測定する。対照には血清の代わりに精製水を用い
た。その結果は図1に示す様に原点を通る良好な直線性
の検量線が得られ、これにより血清の酵素活姓を正確に
求めることができる。実施例 3
(一般式(1)においてYがプロピレン、R1、R2が
エチル基、R3がニトロ基、R4がメトキシ基、Xが塩
素原子で、置換アルコキシ基がベンゼン環の3位に置換
した化合物の合成法。Immediately add 1 ml of 0.1N hydrochloric acid, and measure the absorbance at 590 nm. Purified water was used instead of serum as a control. As a result, as shown in FIG. 1, a calibration curve with good linearity passing through the origin was obtained, and thereby the enzyme activity of the serum could be accurately determined. Example 3 (Compound in which Y is propylene, R1 and R2 are ethyl groups, R3 is a nitro group, R4 is a methoxy group, X is a chlorine atom, and a substituted alkoxy group is substituted at the 3-position of the benzene ring in general formula (1)) synthesis method.
)3−ヒドロキシベンズアルデヒド1227と1・3−
ジクロロプロピレン5007をテトラヒドロフランに溶
かし、これに水酸化ナトリウム溶液を加え加熱還流させ
た後減圧蒸留して、3−(3クロロプロポキシ)ベンズ
アルデヒド1187を得る。次に、この3−(3−クロ
ロポキシ)ベンズアルデヒド63.57と4−ニトロフ
エニルヒドラジン467をメタノール中で加温混合し、
3(3−クロロプロポキシ)ベンズアルデヒド−4ニト
ロフエニルヒドラゾン877を合成する。このヒドラゾ
ン53yにO−ジアニシジンテトラゾニウムホウフツ化
塩307と共にテトラヒドロフランに懸濁させ冷却する
。これに水酸化カリウム溶液を徐々に滴下し、2時間攪
拌する。反応溶液にメタノールを加え一夜放置して沢過
し、427の1・11−(3・3′−ジメトキシ−4・
4′−ビフエニリレン)−ビス{5−(4−ニトロフエ
ニル)−3−〔3−(3−クロロプロポキシ)フエニル
〕}ジホルマザンを得る。このホルマザン30yと酸化
銅粉末をトリエチルアミンとジオキサンの混合溶媒中に
懸濁させ、加熱還流しながら反応させた後、メタノール
を加えて沢過し沢液を減圧濃縮して、ジホルマザン側鎖
の4級化アンモニウム塩化合物137を得る。この4級
アンモニウム塩10tをメタノールに溶解し、塩酸を加
え室温で攪拌しながらここへ亜硝酸ブチル12yを滴下
し反応させる。反応溶液に活性炭を加え沢過し減圧濃縮
して、目的とするテトラゾリウム塩化物87を得る。融
点 152〜155℃(分解)
元素分析値(%)C53H7ONl2O8Cl4実施例
4(一般式(1)においてYが2−ヒドロキシメチル
エチレン、R1、R2がプロピル基、R3が水素原子、
R4がメトキシ基、Xが塩素原子で、置換アルコキシ基
がベンゼン環の4位に置換した化合物の合成法。) 3-Hydroxybenzaldehyde 1227 and 1,3-
Dichloropropylene 5007 is dissolved in tetrahydrofuran, a sodium hydroxide solution is added thereto, the mixture is heated to reflux, and then distilled under reduced pressure to obtain 3-(3chloropropoxy)benzaldehyde 1187. Next, 63.57 of this 3-(3-chloropoxy)benzaldehyde and 467 of 4-nitrophenylhydrazine were heated and mixed in methanol,
3(3-chloropropoxy)benzaldehyde-4nitrophenylhydrazone 877 is synthesized. This hydrazone 53y and O-dianisidine tetrazonium borofluoride salt 307 are suspended in tetrahydrofuran and cooled. Potassium hydroxide solution was gradually added dropwise to this, and the mixture was stirred for 2 hours. Add methanol to the reaction solution, leave it overnight and filter it to obtain 1,11-(3,3'-dimethoxy-4,427).
4'-biphenylylene)-bis{5-(4-nitrophenyl)-3-[3-(3-chloropropoxy)phenyl]}diformazan is obtained. This formazan 30y and copper oxide powder were suspended in a mixed solvent of triethylamine and dioxane, and reacted while heating and refluxing. Methanol was added thereto, and the slurry was concentrated under reduced pressure to form a quaternary diformazane side chain. Ammonium salt compound 137 is obtained. 10 t of this quaternary ammonium salt is dissolved in methanol, hydrochloric acid is added thereto, and 12 y of butyl nitrite is added dropwise thereto while stirring at room temperature for reaction. Activated carbon is added to the reaction solution, filtered and concentrated under reduced pressure to obtain the desired tetrazolium chloride 87. Melting point 152-155°C (decomposed) Elemental analysis value (%) C53H7ONl2O8Cl4 Example 4 (In general formula (1), Y is 2-hydroxymethylethylene, R1 and R2 are propyl groups, R3 is a hydrogen atom,
A method for synthesizing a compound in which R4 is a methoxy group, X is a chlorine atom, and a substituted alkoxy group is substituted at the 4-position of the benzene ring.
)実施例1で得られた4−オキシランメトキシベンズア
ルデヒド23yを濃塩酸中にゆつくり滴下し攪拌した後
、クロロホルムを加え冷希炭酸水素ナトリウム水溶液、
次に冷水で洗浄し溶媒を留去して、4−(2−クロロ−
3−ヒドロキシプロポキシ)ベンズアルデヒド26yを
得る。) 4-oxirane methoxybenzaldehyde 23y obtained in Example 1 was slowly dropped into concentrated hydrochloric acid and stirred, then chloroform was added and a cold dilute aqueous sodium bicarbonate solution was added.
Next, the solvent was distilled off after washing with cold water, and the 4-(2-chloro-
3-Hydroxypropoxy)benzaldehyde 26y is obtained.
次に4(2−クロロ−3−ヒドロキシプロポキシ)ベン
ズアルデヒド20yとフエニルヒドラジン107をメタ
ノール中で加温混合し、4−(2−クロロ3−ヒドロキ
シプロポキシ)ベンズアルデヒドフエニルヒドラゾン2
57を合成する。このヒドラゾン207をテトラヒドロ
フランに溶かし冷却しながら、水酸化カリウム溶液を少
しずつ加えた後、O−ジアニシジンテトラゾニウムホウ
フツ化塩157を少しずつ添加する。2時間攪拌した後
、反応溶液にメタノールを加え一夜放置し沢過して、1
2f7の1・1′−(3・3′−ジメトキシ−4・4′
ビフエニリレン)−ビス{5−フエニル一3〔4−(2
−クロロ−3−ヒドロキシプロポキシ)フエニル〕}ジ
ホルマザンを得る。Next, 20y of 4(2-chloro-3-hydroxypropoxy)benzaldehyde and 107 phenylhydrazine were mixed in methanol while heating, and 4-(2-chloro3-hydroxypropoxy)benzaldehyde phenylhydrazone 2
Synthesize 57. This hydrazone 207 is dissolved in tetrahydrofuran and while cooling, a potassium hydroxide solution is added little by little, and then O-dianisidine tetrazonium borofluoride salt 157 is added little by little. After stirring for 2 hours, methanol was added to the reaction solution, allowed to stand overnight, and filtered thoroughly.
2f7 1・1′-(3・3′-dimethoxy-4・4′
biphenylylene)-bis{5-phenyl-3[4-(2
-chloro-3-hydroxypropoxy)phenyl]} diformazan is obtained.
このホルマザン107をトリプロピルアミンとジオキサ
ンの混合溶媒中に懸濁させ加熱撹拌した後、メタノール
を加え沢過し沢液を減圧濃縮して、ジホルマザン側鎖の
4級アンモニウム塩6.37を得る.。この4級アンモ
ニウム塩57をメタノールに溶解し塩酸を加え室温で攪
拌しながらここへ亜硝酸ブチル4.47を加えて反応さ
せる。.反応溶液を減圧濃縮し、目的とするテトラゾリ
ウム塩化物5.2yを得る。融点 126〜13「C(
分解)
元素分析値(%)C64H84NlOCl4O6、H2
O実施例 5(実施例4で得られた化合物を用いる脱水
素酵素の吸光光度定量法。This formazan 107 is suspended in a mixed solvent of tripropylamine and dioxane, heated and stirred, then methanol is added, filtered, and the slurry is concentrated under reduced pressure to obtain 6.37 of the quaternary ammonium salt of the diformazane side chain. . This quaternary ammonium salt 57 is dissolved in methanol, hydrochloric acid is added thereto, and 4.47 g of butyl nitrite is added thereto while stirring at room temperature for reaction. .. The reaction solution is concentrated under reduced pressure to obtain 5.2y of the desired tetrazolium chloride. Melting point 126~13"C (
Decomposition) Elemental analysis value (%) C64H84NlOCl4O6, H2
Example 5 (Spectrophotometric determination of dehydrogenase using the compound obtained in Example 4).
)実施例2と同様の測定操作により図2に示すように感
度は低いが原点を通り良好な直線性の検量線が得られた
。) By the same measurement procedure as in Example 2, a calibration curve with good linearity passing through the origin was obtained, although the sensitivity was low, as shown in FIG.
なお該化合物は0.0698%溶液として用い測定は5
90nmで行つた。実施例 6
(一般式(1)においてYが2−ヒドロキシフロピレン
、R1がメチル基、R2がベンジル基、R3、R4が水
素原子、Xが塩素原子で、置換アルコキシがベンゼン環
の3位に置換した化合物の合成法。The compound was measured as a 0.0698% solution at 5%
It was performed at 90 nm. Example 6 (In general formula (1), Y is 2-hydroxypropylene, R1 is a methyl group, R2 is a benzyl group, R3 and R4 are hydrogen atoms, X is a chlorine atom, and substituted alkoxy is at the 3-position of the benzene ring) Synthesis of substituted compounds.
)3−ヒドロキシベンズアルデヒド867とエピクロル
ヒドリン1307をテトラヒドロフランに溶かし、これ
に水酸化ナトリウム溶液を加え加熱還流させた後減圧蒸
留して、3−オキシランメトキシベンズアルデヒド75
′F7を得る。) 3-Hydroxybenzaldehyde 867 and epichlorohydrin 1307 were dissolved in tetrahydrofuran, a sodium hydroxide solution was added thereto, the mixture was heated to reflux, and then distilled under reduced pressure to obtain 3-oxiranemethoxybenzaldehyde 75.
’F7 is obtained.
次に、3一オキシランメトキシベンズアルデヒド107
とフエニルヒドラジン67をメタノール中で加温混合し
、一夜放置したのち冷却し、攪拌しながらジメチルアミ
ン127をメタノールに溶かして加え、反応させ徐々に
室温にもどした後溶媒留去し、3(2−ヒドロキシ−3
−ジメチルアミノプロポキシ)ベンズアルデヒドフエニ
ルヒドラゾン177を得る。得られたヒドラゾン137
をテトラヒドロフランに溶かし、それに水酸化カリウム
溶液を加え冷却する。これにジベンジジンのジアゾニウ
ム塩酸塩水溶液を少しずつ加え2時間攪拌する。反応溶
液にメタノール200m1を加え一夜放置して沢過し、
1・11−(4・47−ビフエニリレン)ビス{5−フ
エニル一5−〔3−(2−ヒドロキシ−3−ジメチルア
ミノプロポキシ)フエニル〕}ジホルマザンを得る。得
られたホルマザンJモVと酸化銅粉末を塩化ベンジルとジ
オキサンの混合溶媒中に懸濁させ攪拌した後、メタノー
ルを加えて沢加し沢液を減圧濃縮し、ジホルマザン側鎖
の4級アンモニウム塩5.5yを得る。この4級アンモ
ニウム塩5yをメタノールに溶解し、これに塩酸を加え
攪拌しながら亜硝酸ブチル4.87を加え反応させる。
反応溶液を沢過し減圧濃縮して、目的とするビステトラ
ゾリウム塩化物5.17を得る。融点 136〜142
℃(分解)元素分析値(%)C62H64NlOO4C
l4実施例 7(一般式(1)においてYがブチレン、
R1がエチル基、R2が2・3−ジヒドロキシプロピル
基、R3が水素原子、R4がメトキシ基、Xが塩素原子
で、置換アルコキシ基がベンゼン環の4位に置換した化
合物の合成法。Next, 3-oxirane methoxybenzaldehyde 107
and phenylhydrazine 67 were heated and mixed in methanol, allowed to stand overnight, cooled, dimethylamine 127 was dissolved in methanol and added while stirring, allowed to react, and the temperature was gradually returned to room temperature, then the solvent was distilled off, and 3( 2-hydroxy-3
-dimethylaminopropoxy)benzaldehyde phenylhydrazone 177 is obtained. Obtained hydrazone 137
Dissolve in tetrahydrofuran, add potassium hydroxide solution and cool. A diazonium hydrochloride aqueous solution of dibenzidine was added little by little to this and stirred for 2 hours. Add 200ml of methanol to the reaction solution, leave it overnight, and filter thoroughly.
1,11-(4,47-biphenylylene)bis{5-phenyl-5-[3-(2-hydroxy-3-dimethylaminopropoxy)phenyl]}diformazan is obtained. The obtained formazan JMo V and copper oxide powder were suspended in a mixed solvent of benzyl chloride and dioxane and stirred, then methanol was added and the slurry was concentrated under reduced pressure to obtain the quaternary ammonium salt of the diformazan side chain. Get 5.5y. This quaternary ammonium salt 5y is dissolved in methanol, hydrochloric acid is added thereto, and while stirring, 4.87 g of butyl nitrite is added and reacted.
The reaction solution is thoroughly filtered and concentrated under reduced pressure to obtain the desired bistetrazolium chloride 5.17. Melting point 136-142
°C (decomposition) elemental analysis value (%) C62H64NlOO4C
l4 Example 7 (In general formula (1), Y is butylene,
A method for synthesizing a compound in which R1 is an ethyl group, R2 is a 2,3-dihydroxypropyl group, R3 is a hydrogen atom, R4 is a methoxy group, X is a chlorine atom, and a substituted alkoxy group is substituted at the 4-position of the benzene ring.
)4−ヒドロキシベンズアンデヒド84yと1・4−ジ
クロロブタン440yをテトラヒドロフランに溶かし、
これに水酸化ナトリウム溶液を加え加熱還流させた後減
圧蒸留して、4−(4−クロロブトキシ)ベンズアルデ
ヒド627を得る。) Dissolve 84y of 4-hydroxybenzandehyde and 440y of 1,4-dichlorobutane in tetrahydrofuran,
A sodium hydroxide solution is added to this, heated to reflux, and then distilled under reduced pressure to obtain 4-(4-chlorobutoxy)benzaldehyde 627.
次にこの4−(4−クロブトキシ)ベンズアルデヒド2
87とフエニルヒドラジン14.27をメタノール中で
加温混合し、4−(4−クロロブトキシ)ベンズアルデ
ヒドフエニルヒドラゾン29yを合成する。このヒドラ
ゾン157をメタノールとテトラヒドロフランQ混合溶
媒に溶かし攪拌しながらジエチルアミン21yを加え還
流後減圧濃縮し、4−(4−ジエチルアミノブトキシ)
ベンズアルデヒドフエニルヒドラゾン137を得る。得
られたヒドラゾン13fとO−ジアニシジンテトラゾニ
ウムホウフツ化塩8.57をテトラヒドロフランに懸濁
させ冷却する。これに水酸化カリウム溶液を徐々に滴下
し3時間攪拌した後、メタノールを加え一夜放置してf
過し、10,27の3・3/−(1・11−ジメトキシ
−4・4!−ビフエニリレン)−ビス{5−フエニル一
3−〔4−(4−ジエチルアミノブトキシ)フエニル〕
}ジホルマザンを得る。得られたホルマザン4.67を
テトラヒドロフランに溶かし、3−クロロ−1・2−ジ
ヒドロキシプロパン257を加え加熱還流した後、メタ
ノールを加えて沢過し沢液を減圧濃縮して、ジホルマザ
ン側鎖の4級アンモニウム塩5.27を得る。この4級
アンモニウム塩4.2yをメタノールに溶解しそれに塩
酸を加え室温で撹拌しながらここへ亜硝酸ブチル3.7
7を加えて反応させる。反応溶液に活件炭を入れ処理し
た後沢過し減圧濃縮して、目的とするテトラゾリウム塩
化物4.87を得る。融点 72〜78℃元素分析値(
%)C62H8ONlOO8Cl4・2H20実施例
8(実施例7で得られた化合物を用いる脱水素酵素の吸
光光度定量法。Next, this 4-(4-chlorobutoxy)benzaldehyde 2
87 and phenylhydrazine 14.27 are mixed under heating in methanol to synthesize 4-(4-chlorobutoxy)benzaldehyde phenylhydrazone 29y. This hydrazone 157 was dissolved in a mixed solvent of methanol and tetrahydrofuran Q, and diethylamine 21y was added while stirring, refluxed and concentrated under reduced pressure to produce 4-(4-diethylaminobutoxy).
Benzaldehyde phenylhydrazone 137 is obtained. The obtained hydrazone 13f and O-dianisidine tetrazonium borofluoride salt 8.57 are suspended in tetrahydrofuran and cooled. After gradually adding potassium hydroxide solution dropwise and stirring for 3 hours, methanol was added and left overnight.
3,3/-(1,11-dimethoxy-4,4!-biphenylylene)-bis{5-phenyl-3-[4-(4-diethylaminobutoxy)phenyl]
}Obtain diformazan. The resulting formazan 4.67 was dissolved in tetrahydrofuran, 3-chloro-1,2-dihydroxypropane 257 was added, and the mixture was heated to reflux. Methanol was added thereto, and the filtrate was concentrated under reduced pressure. 5.27 of grade ammonium salt is obtained. Dissolve 4.2y of this quaternary ammonium salt in methanol, add hydrochloric acid to it, and add 3.7y of butyl nitrite while stirring at room temperature.
Add 7 and react. After treating the reaction solution with activated carbon, it is filtered and concentrated under reduced pressure to obtain 4.87 g of the desired tetrazolium chloride. Melting point: 72-78℃ Elemental analysis value (
%)C62H8ONlOO8Cl4・2H20 Example
8 (Spectrophotometric determination of dehydrogenase using the compound obtained in Example 7).
)実施例2と同様の測定操作により図2に示すように原
点を通り良好な直線性の検量線が得られた。) A calibration curve with good linearity passing through the origin as shown in FIG. 2 was obtained by the same measurement operation as in Example 2.
なお該化合物は0.0703%溶液として用い測定は5
82nmで行つた。実施例 9
(一般式(1)においてYが2−ヒドロキシイチルエチ
レン、R1、R2がメチル基、R3がニトロ基、R4が
メトキシ基、Xが臭素原子で、置換アルコキシ基がベン
ゼン環の3位に置換した化合物の合成法。The compound was measured as a 0.0703% solution at 5%
It was performed at 82 nm. Example 9 (In general formula (1), Y is 2-hydroxyethylethylene, R1 and R2 are methyl groups, R3 is a nitro group, R4 is a methoxy group, X is a bromine atom, and the substituted alkoxy group is at the 3-position of the benzene ring) A method for synthesizing compounds substituted with .
)実施例6で得られた3−オキシランメトキシベンズア
ルデヒド18yを臭素酸中にゆつくりと滴下し攪拌した
のち、クロロホルムを加え冷希炭酸水素ナトリウム水溶
液、次に冷水で洗浄し溶媒を留去して3−(2−ブロモ
−3−ヒドロキシプロポキシ)ベンズアルデヒド21.
57を得る。) The 3-oxirane methoxybenzaldehyde 18y obtained in Example 6 was slowly dropped into bromic acid and stirred, then chloroform was added and the mixture was washed with a cold dilute aqueous sodium bicarbonate solution and then with cold water, and the solvent was distilled off. 3-(2-bromo-3-hydroxypropoxy)benzaldehyde21.
Get 57.
次にこの3−(2−ブロモ−3−ヒドロキシプロポキシ
)ベンズアルデヒド16yと4−ニトロフエニルヒドラ
ジン197をメタノール中で加温混合し、3−(2−ブ
ロモ−3−ヒドロキシプロポキシ)ベンズアルデヒド−
4−ニトロフエニルヒドラゾン21yを合成する。この
ヒドラゾン127をO−ジアニシジンテトラゾニウムホ
ウフツ化塩6.7?と共にテトラヒドロフランに懸濁さ
せ冷却する。これに水酸化カリウム溶液を徐々に滴下し
2。5時間攪拌する。Next, this 3-(2-bromo-3-hydroxypropoxy)benzaldehyde 16y and 4-nitrophenylhydrazine 197 were heated and mixed in methanol, and 3-(2-bromo-3-hydroxypropoxy)benzaldehyde-
Synthesize 4-nitrophenylhydrazone 21y. This hydrazone 127 is O-dianisidine tetrazonium borofluoride salt 6.7? The mixture is suspended in tetrahydrofuran and cooled. Potassium hydroxide solution was gradually added dropwise to the mixture and stirred for 2.5 hours.
反応溶液にメタノール200111を加え沢過して、8
.52の1・1′−(3・3′−ジメトキシ−4・4′
−ビフエニリレン)−ビス{5−(4−ニトロフエニル
)−3−〔3−(2−フロモー3−ヒドロキシプロポキ
シ)フエニル〕}ジホルマザンを得る。得られたジホル
マザン87と酸化銅粉末をトリメチルアミン水溶液中に
懸濁させ攪拌した後、メタノールを加えて沢過し沢液を
減圧濃縮して、ジホルマザン側鎖の4級アンモニウム塩
5.21を得る。この4級アンモニウム塩47をメタノ
ールに溶解し、これにNBSl.67を少しずつ加えて
反応させる。反応溶液を沢過し減圧濃縮して、目的とす
るテトラゾリウム臭化物3.87を得る。融点 175
〜180℃(分解)
元素分析値(%)C52H58Nl2OlOBr4(一
般式(1)においてYが2−ヒドロキシプロピレン、R
1、R2が2−ヒドロキシエチル基、R3がニトロ基、
R4がメトキシ基、Xが塩素原子で置換アルコキシ基が
ベンゼン環の4位に置換した化合物の合成法)実施例1
で得られた4−オキシランメトキシベンズアルデヒド−
4−ニトロフエニルヒドラゾン207をテトラヒドロフ
ランに溶かし、更にOジアニシジンテトラゾニウムホウ
フツ化塩127を加え冷却する。Add methanol 200111 to the reaction solution, filter it, and
.. 52-1,1'-(3,3'-dimethoxy-4,4'
-biphenylylene)-bis{5-(4-nitrophenyl)-3-[3-(2-furomo-3-hydroxypropoxy)phenyl]}diformazan is obtained. The obtained diformazan 87 and copper oxide powder are suspended in an aqueous trimethylamine solution and stirred, then methanol is added and the filtered slurry is concentrated under reduced pressure to obtain a quaternary ammonium salt of diformazan side chain 5.21. This quaternary ammonium salt 47 was dissolved in methanol, and NBSl. Add 67 little by little and react. The reaction solution was filtered and concentrated under reduced pressure to obtain 3.87 g of the desired tetrazolium bromide. Melting point 175
~180℃ (decomposition) Elemental analysis value (%) C52H58Nl2OlOBr4 (in general formula (1), Y is 2-hydroxypropylene, R
1, R2 is a 2-hydroxyethyl group, R3 is a nitro group,
Synthesis method of a compound in which R4 is a methoxy group, X is a chlorine atom, and a substituted alkoxy group is substituted at the 4-position of the benzene ring) Example 1
4-Oxiranmethoxybenzaldehyde obtained in
4-Nitrophenylhydrazone 207 is dissolved in tetrahydrofuran, O dianisidine tetrazonium borofluoride salt 127 is further added, and the mixture is cooled.
これに水酸化カリウム水溶液を滴下し、2時間撹拌する
。反応溶液にメタノールを加え沢過し167の1・「−
(3・3′−ジメトキシ−4・4!−ビフエニリレン)
−ビス{5(4−ニトロフエニル)−3−(4−オキシ
ランメトキシ)フエニル}ホルマザンを得る。得られた
ジホルマザンを塩酸存在下、メタノールに懸濁させ、そ
れにトリエタノールアミンを加え20時間加熱する。P
液を濃縮しテトラヒドロフランで処理して、ジホルマザ
ン側鎖の4級アンモニウム塩167を得る。4級アンモ
ニウム塩107をメタノールに溶かし、それに塩酸を加
え室温で攪拌しながら亜硝酸n−ブチルを加えて反応さ
せる。An aqueous potassium hydroxide solution was added dropwise to this, and the mixture was stirred for 2 hours. Add methanol to the reaction solution and filter it.
(3,3'-dimethoxy-4,4!-biphenylylene)
-bis{5(4-nitrophenyl)-3-(4-oxiranemethoxy)phenyl}formazan is obtained. The obtained diformazan is suspended in methanol in the presence of hydrochloric acid, triethanolamine is added thereto, and the suspension is heated for 20 hours. P
The liquid is concentrated and treated with tetrahydrofuran to obtain the quaternary ammonium salt 167 of the diformazane side chain. Quaternary ammonium salt 107 is dissolved in methanol, hydrochloric acid is added thereto, and n-butyl nitrite is added and reacted with stirring at room temperature.
反応溶液を沢過し濃縮して目的とするテトラゾリウム塩
化物9.5を得る。融点 183〜19「C(分解)
元素分析値(%)C58H7、Nl2Ol6Cl4The reaction solution is thoroughly filtered and concentrated to obtain the desired tetrazolium chloride 9.5. Melting point 183-19 "C (decomposition) Elemental analysis value (%) C58H7, Nl2Ol6Cl4
図1、図2および図3は、それぞれ実施例2、実施例5
および実施例8によるところの、それぞれ590nm、
590nmおよび82nmにおける吸光度とLDH活性
値の関係をあられす図表である。1, 2 and 3 are Example 2 and Example 5, respectively.
and 590 nm, respectively, according to Example 8.
It is a chart showing the relationship between absorbance at 590 nm and 82 nm and LDH activity value.
Claims (1)
数が2〜4の直鎖式、または側鎖を有しても良く、さら
に必要に応じ1個の水酸基を有しても良いアルキレン基
。 R^1:炭素数1〜4のアルキル基、またはヒドロキシ
エチル基。 R^2:炭素数1〜4で、必要に応じ1〜2個の水酸基
、または1個のフェニル基を有しても良いアルキル基。 R^3:水素原子、またはニトロ基。 R^4:メトキシ基;なおR^3が水素原子のときはR
^4は水素原子であつても良い。 X:塩素原子、または臭素原子。 なお、▲数式、化学式、表等があります▼のベンゼン環
における置換位置は3位、または3位である。 2 一般式 で表わされるビステトラゾリウム塩化合物を用いる脱水
素酵素の吸光光度定量法。 ただし式中の意味はつぎのようである。Y:炭素数が2
〜4の直鎖式、または側鎖を有しても良く、さらに必要
に応じ1個の水酸基を有しても良いアルキレン基。 R^1:炭素数1〜4のアルキル基、またはヒドロキシ
エチル基。 R^2:炭素数1〜4で、必要に応じ1〜2個の水酸基
、または1個のフェニル基を有しても良いアルキル基。 R^3:水素原子、またはニトロ基。 R^4:メトキシ基;なおR^3が水素原子のときは※
▲数式、化学式、表等があります▼で表わされるテトラ
ゾリウム塩化合物およびその化合物を用いる脱水素酵素
の吸光光度定量法に関する。 ただし式中の記号の意味はつぎのようである。Y:炭素
数が2〜4の直鎖式、または側鎖を有しても良く、さら
に必要に応じ1個の水酸基を有▲数式、化学式、表等が
あります▼・・・・・・( I )※ R^4は水素原子
であつても良い。 X:塩素原子、または臭素原子。 なお、▲数式、化学式、表等があります▼のベンゼン環
における置換位置は3位、または4位である。[Claims] 1. A bistetrazolium salt compound represented by the general formula. However, the meanings of the symbols in the formula are as follows. Y: A straight chain type having 2 to 4 carbon atoms, or an alkylene group that may have a side chain and, if necessary, one hydroxyl group. R^1: an alkyl group having 1 to 4 carbon atoms or a hydroxyethyl group. R^2: An alkyl group having 1 to 4 carbon atoms and optionally having 1 to 2 hydroxyl groups or 1 phenyl group. R^3: Hydrogen atom or nitro group. R^4: Methoxy group; When R^3 is a hydrogen atom, R
^4 may be a hydrogen atom. X: chlorine atom or bromine atom. In addition, ▲There are mathematical formulas, chemical formulas, tables, etc. ▼The substitution position on the benzene ring is the 3-position or the 3-position. 2 Spectrophotometric determination of dehydrogenase using a bistetrazolium salt compound represented by the general formula. However, the meaning in the formula is as follows. Y: Number of carbon atoms is 2
~4 straight chain type or alkylene group which may have a side chain and further may have one hydroxyl group as required. R^1: an alkyl group having 1 to 4 carbon atoms or a hydroxyethyl group. R^2: An alkyl group having 1 to 4 carbon atoms and optionally having 1 to 2 hydroxyl groups or 1 phenyl group. R^3: Hydrogen atom or nitro group. R^4: Methoxy group; When R^3 is a hydrogen atom*
▲There are mathematical formulas, chemical formulas, tables, etc.▼Regarding the tetrazolium salt compound represented by ▼ and the method for spectrophotometric determination of dehydrogenase using that compound. However, the meanings of the symbols in the formula are as follows. Y: Linear type with 2 to 4 carbon atoms, or may have a side chain, and if necessary, has one hydroxyl group ▲ Numerical formula, chemical formula, table, etc. are available ▼・・・・・・( I) *R^4 may be a hydrogen atom. X: chlorine atom or bromine atom. In addition, the substitution position in the benzene ring of ▲, which includes mathematical formulas, chemical formulas, tables, etc., is the 3rd or 4th position.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21461981A JPS5939430B2 (en) | 1981-12-26 | 1981-12-26 | Bistetrazolium salt compound and spectrophotometric determination of dehydrogenase using the compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21461981A JPS5939430B2 (en) | 1981-12-26 | 1981-12-26 | Bistetrazolium salt compound and spectrophotometric determination of dehydrogenase using the compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58113182A JPS58113182A (en) | 1983-07-05 |
| JPS5939430B2 true JPS5939430B2 (en) | 1984-09-22 |
Family
ID=16658720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21461981A Expired JPS5939430B2 (en) | 1981-12-26 | 1981-12-26 | Bistetrazolium salt compound and spectrophotometric determination of dehydrogenase using the compound |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5939430B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06253899A (en) * | 1993-03-02 | 1994-09-13 | Toyobo Co Ltd | Reagent composition for measurement of urea nitrogen |
-
1981
- 1981-12-26 JP JP21461981A patent/JPS5939430B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58113182A (en) | 1983-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2757348B2 (en) | New water-soluble tetrazolium salt compound | |
| EP0153872B1 (en) | Method for the determination of the reduced form of nicotinamide adenine dinucleotide | |
| JPS5939430B2 (en) | Bistetrazolium salt compound and spectrophotometric determination of dehydrogenase using the compound | |
| JP2701090B2 (en) | Oxidizable color reagent | |
| JPS603396B2 (en) | Tetrazolium salt compound and spectrophotometric determination of dehydrogenase using the compound | |
| CN100396671C (en) | Water Soluble Tetrazolium Compounds | |
| JP2008526990A (en) | Water-soluble tetrazolium salt | |
| JP2590124B2 (en) | Water-soluble tetrazolium compound and method for measuring reducing substance using the compound | |
| JPS59112973A (en) | Tetrazolium salt compound and method for measuring absorptiometry of dehydrogenase using said compound | |
| US4822891A (en) | 4-amino-2,3-di-substituted-1-(mono- or trichlorophenyl)-3-pyrazolin-5-ones | |
| JPH0770092A (en) | Novel water-soluble tetrazolium compound | |
| JPH01112155A (en) | Method for determination of hydrogen peroxide and reagent for said determination | |
| JP2995380B2 (en) | New water-soluble tetrazolium salt compound | |
| JP2819258B2 (en) | New water-soluble tetrazolium salt compound | |
| JPH0413351B2 (en) | ||
| JP3357667B2 (en) | Substance measurement method | |
| CA2251850C (en) | Water-soluble tetrazolium salt compounds | |
| JPS62234070A (en) | Aminoantipyrine derivative and use thereof | |
| US5164512A (en) | Oxidizable color producing reagent | |
| JPH05229993A (en) | Triphenylmethane derivative | |
| JPH0413352B2 (en) | ||
| JPS59106476A (en) | Water-soluble tetrazolium compound and a method for determining reductive substance using the same | |
| JPS6010025B2 (en) | Water-soluble diaminodiphenylmethane derivatives and their applications | |
| JPH05262716A (en) | Oxidizable color reagent | |
| JP2001352999A (en) | Oxidizing color reagent |